The shRNA-mediated down regulation of CD133 or CD271 in melanoma cells revealed that both markers are inversely correlated, suggesting that CD133 suppresses genes associated with CD271, e.g., AXL and FOXD3 and vice versa [40,86]. The gene discussed is NGFR; the disease is melanoma.